Vexim initiated a new clinical study in France to compare 1-year and 2-year follow-up of SpineJack® vs. bracing in 100 acute traumatic vertebral compression fracture patients.
Bio2 Technologies received FDA 510(k) clearance to market a fusion system for interphalangeal fusion, fracture repair and osteotomies of toes, fingers and other small bones. Limited product launch is slated for 2Q16.
MiMedx signed a definitive agreement to acquire Stability Biologics for US $10MM in cash and stock. Stability Biologics provides human tissue products for the surgical, spine and orthopaedic industries. The transaction is expected to close in early 1Q16.
CartiHeal completed a US $15MM financing round. Funds will support ongoing manufacturing scale-up, EU product commercialization in 2017 and clinical studies in new therapeutic areas for Agili-Câ„¢ cartilage regeneration technology.Â
K2M confirmed the first surgical case performed using the CASCADIA™ Lateral Interbody System featuring Lamellar Titanium Technology™, in late 4Q15.
Intellijoint Surgical received FDA 510(k) clearance to market the next-generation intellijioint HIPâ„¢ surgical smart tool, now including cup position (inclination and anteversion).